Specific targeted hDGK theta gene luciferase reporting system
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHAANXI NORMAL UNIV
- Publication Date
- 2018-08-03
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] The invention belongs to the fields of biotechnology and pharmacology, and relates to a luciferase reporter system, in particular to a luciferase reporter system specifically targeting hDGKθ gene, which can be used for expression of endogenous human diacylglycerol kinase (hDGKθ) Activity monitoring can also be used to screen new drugs that regulate DGKθ. Background technique
[0002] Diacylglycerol Kinases (DGKs) are important endogenous lipid-regulating enzymes, which can simultaneously regulate the concentration of two second messengers in cells—DAG and PA, and participate in various signaling pathways in cells. DGKθ is the only isoform of DGKs isoenzyme type V, and it is also one of the least understood DGK subtypes. DGKθ was originally discovered in mouse brain tissue and structurally contains three cysteine-rich domains (CRD), which distinguish it from other isoforms (containing two CRD domains). In addition, its N-terminus has a proline / glycine-rich domain, pleck...